BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19799110)

  • 1. NOD-like receptors--pivotal guardians of the immunological integrity of barrier organs.
    Rosenstiel P; Schreiber S
    Adv Exp Med Biol; 2009; 653():35-47. PubMed ID: 19799110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.
    Tattoli I; Travassos LH; Carneiro LA; Magalhaes JG; Girardin SE
    Semin Immunopathol; 2007 Sep; 29(3):289-301. PubMed ID: 17690884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
    Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
    Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
    Correa RG; Milutinovic S; Reed JC
    Biosci Rep; 2012 Dec; 32(6):597-608. PubMed ID: 22908883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different roles of innate immune receptors in inflammation and carcinogenesis between races.
    Yamaguchi N; Suzuki Y; Mahbub MH; Takahashi H; Hase R; Ishimaru Y; Sunagawa H; Watanabe R; Eishi Y; Tanabe T
    Environ Health Prev Med; 2017 Oct; 22(1):70. PubMed ID: 29165176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three Nod-like receptors and their role in antimicrobial responses of goldfish (Carassius auratus L.) macrophages to Aeromonas salmonicida and Mycobacterium marinum.
    Xie J; Hodgkinson JW; Katzenback BA; Kovacevic N; Belosevic M
    Dev Comp Immunol; 2013 Mar; 39(3):180-7. PubMed ID: 23194927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unleashing the therapeutic potential of NOD-like receptors.
    Geddes K; Magalhães JG; Girardin SE
    Nat Rev Drug Discov; 2009 Jun; 8(6):465-79. PubMed ID: 19483708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
    Jakopin Ž
    J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.
    Coutermarsh-Ott S; Eden K; Allen IC
    J Gen Virol; 2016 Apr; 97(4):825-838. PubMed ID: 26763980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD-like receptors (NLRs): bona fide intracellular microbial sensors.
    Shaw MH; Reimer T; Kim YG; Nuñez G
    Curr Opin Immunol; 2008 Aug; 20(4):377-82. PubMed ID: 18585455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization, expression and functional analysis of NOD1, NOD2 and NLRC3 in Nile tilapia (Oreochromis niloticus).
    Gao FY; Pang JC; Lu MX; Yang XL; Zhu HP; Ke XL; Liu ZG; Cao JM; Wang M
    Fish Shellfish Immunol; 2018 Feb; 73():207-219. PubMed ID: 29242132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular NOD-like receptors in host defense and disease.
    Kanneganti TD; Lamkanfi M; Núñez G
    Immunity; 2007 Oct; 27(4):549-59. PubMed ID: 17967410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation.
    Magalhaes JG; Rubino SJ; Travassos LH; Le Bourhis L; Duan W; Sellge G; Geddes K; Reardon C; Lechmann M; Carneiro LA; Selvanantham T; Fritz JH; Taylor BC; Artis D; Mak TW; Comeau MR; Croft M; Girardin SE; Philpott DJ
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14896-901. PubMed ID: 21856952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD1 and NOD2 receptors: integral members of the innate and adaptive immunity system.
    Antosz H; Osiak M
    Acta Biochim Pol; 2013; 60(3):351-60. PubMed ID: 23901396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic analysis of buffalo (Bubalus bubalis) NOD1 and NOD2 receptors and their functional role in in-vitro cellular immune response.
    Brahma B; Kumar S; De BC; Mishra P; Patra MC; Gaur D; Chopra M; Gautam D; Mahanty S; Malik H; Malakar D; Datta TK; De S
    PLoS One; 2015; 10(3):e0119178. PubMed ID: 25786158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod-like receptors are critical for gut-brain axis signalling in mice.
    Pusceddu MM; Barboza M; Keogh CE; Schneider M; Stokes P; Sladek JA; Kim HJD; Torres-Fuentes C; Goldfild LR; Gillis SE; Brust-Mascher I; Rabasa G; Wong KA; Lebrilla C; Byndloss MX; Maisonneuve C; Bäumler AJ; Philpott DJ; Ferrero RL; Barrett KE; Reardon C; Gareau MG
    J Physiol; 2019 Dec; 597(24):5777-5797. PubMed ID: 31652348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular NOD-like receptors in innate immunity, infection and disease.
    Franchi L; Park JH; Shaw MH; Marina-Garcia N; Chen G; Kim YG; Núñez G
    Cell Microbiol; 2008 Jan; 10(1):1-8. PubMed ID: 17944960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
    Caruso R; Warner N; Inohara N; Núñez G
    Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.